Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JonesTrading Upgrades Deciphera Pharmaceuticals to Hold

JonesTrading Upgrades Deciphera Pharmaceuticals to Hold

JonesTrading analyst Soumit Roy upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Sell to Hold.

byBenzinga Newsdesk

January 6, 2023

1 minute read

JonesTrading analyst Soumit Roy upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Sell to Hold.

Louisiana-Pacific Shares Drop After Clocking 16% Sales Decline In Q4

By Anusuya Lahiri

February 21, 9:43 AM

Louisiana-Pacific Corp (NYSE: LPX) reported a fourth-quarter FY22 sales decline of 16% year-on-year to $705 million,

LPX

Analyst Ratings

Truist Securities Maintains Hold Rating for Corporate Office Props Tr: Here’s What You Need To Know

By Benzinga Insights

September 5, 1:00 PM

Truist Securities has decided to maintain its Hold rating of Corporate Office Props Tr (NYSE:OFC) and raise its…

OFC

‘Thoughtworks Lays Off Around 500 Employees Amid Ongoing Slowdown’ – Tech Crunch

By Happy Mohamed

March 1, 12:45 PM

https://techcrunch.com/2023/03/01/thoughtworks-layoffs-economic-slowdown/ Thoughtworks has emerged as the latest tech company to join the ongoing trend of laying off employees amid the global economic slowdown. The

TWKS

Analyst Ratings

The Latest Analyst Ratings for Foot Locker

By Benzinga Insights

April 17, 11:02 AM

Over the past 3 months, 14 analysts have published their opinion on Foot Locker (NYSE:FL) stock. These analysts…

JonesTrading Upgrades Deciphera Pharmaceuticals to Hold

Related Posts

Louisiana-Pacific Shares Drop After Clocking 16% Sales Decline In Q4

Truist Securities Maintains Hold Rating for Corporate Office Props Tr: Here’s What You Need To Know

‘Thoughtworks Lays Off Around 500 Employees Amid Ongoing Slowdown’ – Tech Crunch

The Latest Analyst Ratings for Foot Locker